SPRINGWORKS THERAPEUTICS INC (SWTX)
US85205L1070 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 118.03M | 176.05M | 67.50M | 104.00M | 147.10M | |||
| Marketable Securities | 318.55M | 303.15M | 524.70M | 269.50M | 361.40M | |||
| Receivables | 15.53M | 5.93M | N/A | N/A | N/A | |||
| Inventories | 5.22M | 3.10M | N/A | N/A | N/A | |||
| Other Current Assets | 14.47M | 12.68M | 7.50M | 9.40M | 4.90M | |||
| Total Current Assets | 471.80M | 500.91M | 599.80M | 382.90M | 513.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.08M | 24.09M | 18.30M | 4.20M | 3.00M | |||
| Investments And Advances | 145.57M | 185.34M | 9.00M | 62.10M | 57.20M | |||
| Intangibles | N/A | 11.20M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 15.38M | 4.25M | 3.20M | 3.30M | 2.60M | |||
| Total Non-Current Assets | 185.03M | 224.88M | 30.40M | 69.60M | 62.80M | |||
| TOTAL ASSETS | 656.83M | 725.79M | 630.20M | 452.50M | 576.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 483.00K | 1.16M | 1.40M | |||
| Accrued Expenses | 57.25M | 66.63M | 39.70M | 26.50M | 16.30M | |||
| Accounts Payable | 7.01M | 7.40M | 8.00M | 3.40M | 1.40M | |||
| Other Current Liabilities | 4.65M | 4.14M | 3.30M | N/A | 0.00 | |||
| Total Current Liabilities | 68.92M | 78.17M | 51.00M | 30.00M | 17.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.48M | 21.40M | 21.00M | 100.00K | 1.50M | |||
| Total Non-Current Liabilities | 20.48M | 21.40M | 21.10M | 100.00K | 1.50M | |||
| TOTAL LIABILITIES | 89.39M | 99.57M | 72.10M | 30.10M | 19.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -982.42M | -895.03M | -569.90M | -292.50M | -118.60M | |||
| Additional Paid In Capital | 1.56B | 1.52B | 1.13B | 715.20M | 675.60M | |||
| Common Shares | 7.00K | 7.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -10.64M | -4.14M | -1.30M | N/A | N/A | |||
| Other Shareholders' Equity | -113.00K | 1.19M | -800.00K | -300.00K | 0.00 | |||
| Shares Outstanding | 74.06M | 73.49M | 62.40M | 49.20M | 48.80M | |||
| Tangible Book Value per Share | 7.66 | 8.37 | 8.95 | 8.59 | 11.42 | |||
| Total Shareholders' Equity | 567.44M | 626.22M | 558.20M | 422.40M | 557.10M | |||
| TOTAL LIABILITIES AND EQUITY | 656.83M | 725.79M | 630.20M | 452.50M | 576.20M | |||
| Statistics | ||||||||
| Current Ratio | 6.85 | 6.41 | 11.76 | 12.76 | 29.17 | |||
| Return On Assets (ROA) | -51.62% | -44.79% | -44.02% | -38.43% | -7.91% | |||
| Return On Equity (ROE) | -59.76% | -51.92% | -49.70% | -41.17% | -8.18% | |||
All data in USD